The known mechanisms by which RTKs promote breast cancer progression, maintain cancer stem cell phenotypes and drug resistance involve the regulation of MAPK, JAK/STAT, and phosphoinositide 3-kinase (PI3K)/Akt pathways [8–11], as shown in Figure 1. The gene discussed is AKT1; the disease is breast carcinoma.